Rachael K Seib1, James E Paul. 1. School of Undergraduate Medicine, McMaster University, Hamilton, Ontario L9H 2E8, Canada. rachaelseib@sympatico.ca
Abstract
PURPOSE: Gabapentin's role in the treatment of chronic neuropathic pain is well known. What is less well established is its role for managing postoperative pain. In order to clarify whether gabapentin's utility in acute pain control is more than just theoretical, we conducted a meta-analysis of all randomized trials that addressed gabapentin's role in acute postoperative pain control. We specifically addressed whether gabapentin reduces pain scores, analgesia consumption, and/or analgesia-related side effects in the first 24 hr following surgery. SOURCE: We identified eight placebo-controlled, randomized controlled trials and conducted a meta-analysis using the primary outcomes of pain scores, total analgesia consumption, and side effects over a 24-hr period. PRINCIPLE FINDINGS: Patients who received gabapentin preoperatively reported significantly lower pain scores (-11.9 at rest and -11.0 with movement on a 100-point visual analogue scale) and opioid consumption (-14.7 mg of morphine in 24 hr) with no difference in the incidence of side effects. CONCLUSION: Although gabapentin given preoperatively decreases pain scores and analgesic consumption in the first 24 hr after surgery, the clinical significance of this finding has yet to be determined. This meta-analysis could not demonstrate a significant reduction in the incidence of side effects. Due to the small numbers enrolled in the studies, larger randomized control trials are warranted.
PURPOSE:Gabapentin's role in the treatment of chronic neuropathic pain is well known. What is less well established is its role for managing postoperative pain. In order to clarify whether gabapentin's utility in acute pain control is more than just theoretical, we conducted a meta-analysis of all randomized trials that addressed gabapentin's role in acute postoperative pain control. We specifically addressed whether gabapentin reduces pain scores, analgesia consumption, and/or analgesia-related side effects in the first 24 hr following surgery. SOURCE: We identified eight placebo-controlled, randomized controlled trials and conducted a meta-analysis using the primary outcomes of pain scores, total analgesia consumption, and side effects over a 24-hr period. PRINCIPLE FINDINGS:Patients who received gabapentin preoperatively reported significantly lower pain scores (-11.9 at rest and -11.0 with movement on a 100-point visual analogue scale) and opioid consumption (-14.7 mg of morphine in 24 hr) with no difference in the incidence of side effects. CONCLUSION: Although gabapentin given preoperatively decreases pain scores and analgesic consumption in the first 24 hr after surgery, the clinical significance of this finding has yet to be determined. This meta-analysis could not demonstrate a significant reduction in the incidence of side effects. Due to the small numbers enrolled in the studies, larger randomized control trials are warranted.
Authors: Michelle A O Kinney; Carlos B Mantilla; Paul E Carns; Melissa A Passe; Michael J Brown; W Michael Hooten; Timothy B Curry; Timothy R Long; C Thomas Wass; Peter R Wilson; Toby N Weingarten; Marc A Huntoon; Richard H Rho; William D Mauck; Juan N Pulido; Mark S Allen; Stephen D Cassivi; Claude Deschamps; Francis C Nichols; K Robert Shen; Dennis A Wigle; Sheila L Hoehn; Sherry L Alexander; Andrew C Hanson; Darrell R Schroeder Journal: Pain Pract Date: 2011-06-16 Impact factor: 3.183
Authors: Hance Clarke; Sara Pereira; Deborah Kennedy; Ian Gilron; Joel Katz; Jeffrey Gollish; Joseph Kay Journal: Pain Res Manag Date: 2009 May-Jun Impact factor: 3.037
Authors: Melanie Townsend; Tina Liou; Dorina Kallogjeri; Morgan Schoer; Nicholas Scott-Wittenborn; Miranda Lindburg; Michael Bottros; Ryan S Jackson; Brian Nussenbaum; Jay F Piccirillo Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-11-01 Impact factor: 6.223